Year: 2024

Exclusive

Arkansas Plans to Challenge J&J’s Contested 340B Rebate Proposal for Violation of State Law

September 10, 2024 William Newton, Associate Editor/Senior Writer Views

J&J said its 340B rebate proposal will apply to Arkansas covered entities.

Arkansas plans to challenge Johnson & Johnson’s (J&J’s) 340B rebate proposal for violating the state’s law barring drugmaker contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Another Drug Industry Setback, Maryland Federal Judge Rejects Bids to Block State’s 340B Contract Pharmacy Access Law

September 10, 2024 William Newton, Associate Editor/Senior Writer Views

A federal district judge in Maryland denied multiple drug industry motions in a contract pharmacy lawsuit.

A Maryland federal district judge has denied four separate drug industry attempts to block the state’s contract pharmacy access law—marking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Calls on Congress to Defend 340B Access to Specialty, Community Pharmacies Amid Drugmaker Resistance

September 10, 2024 Bella Czajkowski, National Correspondent Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Pharma-Linked Watchdog Advocacy Group Leader Pens Op-Ed Urging Congress to Advance 340B Legislation

September 10, 2024 Shannon Young, Associate Editor/Senior Writer Views

Tom Schatz, the president of CCAGW and CAGW, urged Congress to "swiftly consider and enact legislation to reform the 340B program” in a Sept. 8 op-ed.

The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Welch Likely to Introduce Senate Version of Matsui’s 340B PATIENTS Act As Soon As Next Week

September 6, 2024 Shannon Young, Associate Editor/Senior Writer Views

U.S. Sen. Peter Welch (D-VT) introduced a Senate version of the 340B PATIENTS Act.

A Vermont Democrat and longtime 340B advocate is expected to soon introduce a Senate version of the 340B Pharmaceutical Access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Experts Forecast Impact of November Elections on 340B Program, Drug Pricing and the Larger Economy

September 6, 2024 Bella Czajkowski, National Correspondent Views

340B Report hosted a subscriber-only webinar on the 2024 elections on Sept. 5.

November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Webinar — Navigating 340B Contract Pharmacy Restrictions: The Latest Developments, Field Insights, and Mitigation Efforts

September 6, 2024 Sponsored Content Views

Join Us September 18th at 1pm EST

HHS Asks D.C. Federal Court to Rule for Drugmakers in Contract Pharmacy Lawsuits, Ties Outcomes to Kalderos 340B Rebate Case

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

HHS filed status reports in five separate ongoing drug industry cases before a federal district court.

The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Maryland, Missouri, West Virginia

September 6, 2024 340B Report Staff Views

Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.

Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live